CTSD and metabolic dysfunction-associated steatohepatitis: Although the results of the current study should be interpreted with caution given the mild changes in inflammation, our data highlight that extracellular CTSD inhibition has favourable effects compared to intracellular inhibition and thus holds potential translational value as observed in a NASH mouse model with a ‘human-like’ lipoprotein profile.